Activation of NF-κB by Reactive Oxygen Intermediates in the Nervous System

被引:90
作者
Kaltschmidt, Barbara [1 ]
Sparna, Titus [1 ]
Kaltschmidt, Christian [1 ]
机构
[1] Univ Freiburg, Mol Neurobiol Lab, D-79104 Freiburg, Germany
关键词
D O I
10.1089/ars.1999.1.2-129
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nuclear factor kappa B (NF-kappa B) is a transcription factor crucially involved in glial and neuronal function. NF-kappa B is ubiquitously distributed within the nervous system, and its inducible activity can be discerned from constitutive activity. Prototypic inducible NF-kappa B in the nervous system is composed of the DNA-binding subunits p50 and p65 complexed with an inhibitory I kappa B-alpha molecule. A number of signals from the cell surface can lead to rapid activation of NK-kappa B, thus releasing the inhibition by I kappa B. This activates translocation of NF-kappa B to the nucleus, where it binds to kappa B motifs of target genes and activates transcription. Previous findings have identified reactive oxygen intermediates (ROI) as a common denominator of NF-kappa B activating signals. More specifically, hydrogen peroxide (H2O2) might be used as second messenger in the NF-kappa B system, despite its cytotoxicity. Analysis of pathways leading to NF-kappa B activation in the nervous system has identified a number of ROI-dependent pathways such as cytokine-and neurotrophin-mediated activation, glutamatergic signal transduction, and various diseases with crucial ROI involvement (e.g., Alzheimer's disease, Parkinson's disease, experimental autoimmune encephalomyelitis, multiple sclerosis, amyotrophic lateral sclerosis, and injury). A number of NF-kappa B-specific target genes contribute to the production of ROl or are involved in detoxification of ROIs. In this review, possible mechanisms and regulatory pathways of ROI-mediated NF-kappa B activation are discussed. Antiox. Redox Signal. 1, 129-144, 1999.
引用
收藏
页码:129 / 144
页数:16
相关论文
共 120 条
[1]   REDOX REGULATION OF FOS AND JUN DNA-BINDING ACTIVITY INVITRO [J].
ABATE, C ;
PATEL, L ;
RAUSCHER, FJ ;
CURRAN, T .
SCIENCE, 1990, 249 (4973) :1157-1161
[2]   INTERLEUKIN-6 MEDIATED DIFFERENTIATION AND RESCUE OF CELL REDOX IN PC12 CELLS EXPOSED TO IONIZING-RADIATION [J].
ABEYAMA, K ;
KAWANO, K ;
NAKAJIMA, T ;
TAKASAKI, I ;
KITAJIMA, I ;
MARUYAMA, I .
FEBS LETTERS, 1995, 364 (03) :298-300
[3]   Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NFκB-dependent mechanism [J].
Akama, KT ;
Albanese, C ;
Pestell, RG ;
Van Eldik, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (10) :5795-5800
[4]   Nitric oxide acts directly in the presynaptic neuron to produce long-term potentiation in cultured hippocampal neurons [J].
Arancio, O ;
Kiebler, M ;
Lee, CJ ;
LevRam, V ;
Tsien, RY ;
Kandel, ER ;
Hawkins, RD .
CELL, 1996, 87 (06) :1025-1035
[5]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[6]   NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules [J].
Baeuerle, PA ;
Baichwal, VR .
ADVANCES IN IMMUNOLOGY, VOL 65, 1997, 65 :111-137
[7]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[8]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[9]  
Baeuerle PA, 1996, PATHOL BIOL, V44, P29
[10]   IκB-NF-κB structures:: At the interface of inflammation control [J].
Baeuerle, PA .
CELL, 1998, 95 (06) :729-731